drugset / Trial / NCT02922946

Study to Determine the Effect of the Timing of a Meal on the Pharmacokinetics of Entinostat

NCT02922946

Phase 1 Completed 47 enrolled Syndax Pharmaceuticals
RandomizedParallel-groupOpen-labelOther

Summary

The objectives of this study are to evaluate the effect of the timing of a moderate-fat meal on the single dose pharmacokinetics of entinostat and to evaluate the safety and tolerability of entinostat under fed and fasting conditions in healthy adult subjects.

Timeline

Start
2016-10-11
Primary completion
2017-05-20
Completion
2017-06-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Entinostat Small molecule 5 mg Oral

Indications

No indication recorded.